Metformin inhibits NF-κB expression by increasing AMPK phosphorylation and inducing Dachshund homologue 1 (DACH1) mRNA expression, thereby reducing MDSCs migration and inhibiting CXCL1 secretion in esophageal carcinoma cells and tumor xenografts. Here, CXCL1 is linked to neoplasm.